A young British woman who was hit with a devastating stage four cancer diagnosis in her late twenties explains how she ...

Tevimbra is under clinical development by BeiGene and currently in Phase I for Ureter Cancer. According to GlobalData, Phase I drugs for Ureter Cancer does not have sufficient historical data to build ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase II drugs for Follicular Lymphoma have a 43% phase transition success ...

A fitness trainer has opened up about how he was diagnosed with cancer, explaining how he 'brushed off' an 'embarrassing' symptom.

At the recent American Society of Hematology annual meeting, early data from the Mithic-FL1 Trial demonstrated impressive ...

Hodgkin Lymphoma Prognosis, Biology Tracked With Circulating Tumor DNA Dec. 11, 2023 — Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma.

Johnny Jackson, a senior at Ridgewood High School, is battling stage 4 Hodgkin's Lymphoma, which first came about last year.

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

This page includes links to articles highlighting the top hematologic cancer research published on Cancer Therapy Advisor in ...

An investigational therapy is demonstrating preclinical promise against non-Hodgkin lymphoma by boosting natural killer cells ...

Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T cell lymphomaVIPER-101 was ...

Period. To cap off yet another successful year, we are sharing some of our best features with you. Enjoy the recap and see you in 2025! Jump to: Features // Lists // Reviews // Interviews // Weird ...